The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
AM-Pharma B.V. announced positive results from its adaptive Phase II study in 301 sepsis patients with Acute Kidney Injury (AKI), the largest ...
read more
Wednesday, March 07, 2018
Protagonist announced that the FDA has granted Orphan Drug Designation for PTG-300, the company's sub-cutaneous injectable hepcidin mimetic for the ...
read more
Biohaven has enrolled the first patient in a Phase 3 clinical trial of the Zydis orally dissolving tablet formulation of rimegepant for the acute ...
read more
Moleac announced the FDA has approved an IND application for a Phase 1 study of MLC1501, as a first step of a clinical program in post-stroke recovery...
read more
Jazz announced the FDA has accepted the company's NDA for solriamfetol for the treatment of excessive sleepiness in adult patients with narcolepsy or ...
read more
Tuesday, February 27, 2018
This year is not the first time we have seen vaccines be less effective against this particular strain of influenza, H3N2.
read more
Monday, February 26, 2018
Shionogi & Co. announced the NDA for lusutrombopag has been accepted for filing and has been granted Priority Review by the FDA.
read more
Friday, February 23, 2018
Mallinckrodt announced the FDA has accepted its NDA seeking approval of its recently acquired developmental product stannsoporfin.
read more
Thursday, February 22, 2018
AbbVie in cooperation with Neurocrine Biosciences, announced that the Phase 3 ELARIS UF-I study (M12-815) of elagolix met its primary endpoint.
read more
Thursday, February 22, 2018
OncoPep announced the initiation of a Phase 1b clinical trial evaluating its investigational vaccine product PVX-410 for the treatment of patients ...
read more
Tuesday, February 20, 2018
AstraZeneca Pharmaceuticals
Ionis Pharmaceuticals has licensed IONIS-AZ5-2.5Rx (AZD2373) to AstraZeneca.
read more
Friday, February 16, 2018
Because of the severity of this season, there have been questions raised about how well this year’s flu vaccine worked.
read more
Wednesday, February 14, 2018
Novartis and the Bill & Melinda Gates Foundation have formed an alliance to advance development of Novartis' drug candidate KDU731 for the treatment ...
read more
Wednesday, February 14, 2018
Ortho Dermatologics announced the FDA accepted the NDA for JEMDEL (IDP-122) lotion with a PDUFA action date of Oct. 5, 2018.
read more
Tuesday, February 13, 2018
MEI Pharma announced a planned interim review of data supports continuation of its multicenter, investigator sponsored, study evaluating ME-344.
read more